Latest Breaking News On - Amarin pharma inc - Page 1 : comparemela.com

FDA Updates Off-Label Communications Guidance - Life Sciences, Biotechnology & Nanotechnology

On October 23, the U.S. Food and Drug Administration (FDA or Agency) released a much anticipated draft guidance entitled.

Opening Moves in the ITC: Strategic Considerations for Pre-Institution Filings in Section 337 Investigations

The period following the filing of a section 337 complaint with the U.S. International Trade Commission (ITC) can be chaotic.. All section 337 litigants confront a series of strategic decisions that can send them on the path to success or failure in the investigation.

Ensuring Innovation Act Changes Eligibility for New Chemical Exclusivity

Law aims to encourage competition in the pharmaceutical industry, making it easier for generics to enter market.

Form DEF 14A AMARIN CORP PLC\UK

Hikma accuses Amarin of suppressing generic versions of heart pill

By Brendan Pierson (Reuters) - Generic drugmaker Hikma Pharmaceuticals USA Inc has sued Amarin Pharma Inc, accusing it of using illegal tactics to del.